Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Antitumor effects reported for EKB-569 plus FOLFIRI in advanced colorectal cancer

Nov. 16, 2004

Ziopharm licenses proprietary form of isophosphoramide mustard

Nov. 16, 2004

Antitumor efficacy of PR-350 plus intraoperative radiotherapy in pancreatic cancer

Nov. 15, 2004

Novartis discloses antitumor agents

Nov. 15, 2004

Protein kinase modulators described in a Sugen patent

Nov. 15, 2004

Selenite sodium reduces radiation-associated diarrhea in uterine cancer patients

Nov. 15, 2004

Novel DpT analogues show potent and selective antitumor activity

Nov. 12, 2004

Novartis selects Vertex collaboration drug candidate for clinical development

Nov. 12, 2004

Dusa and NCI to evaluate Levulan for oral cavity dysplasia

Nov. 12, 2004

Cell Therapeutics researchers claim anticancer compounds

Nov. 12, 2004

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...